Stocks
Novo Nordisk (NVO) EBITDA margin US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 43.4% | 46.4% | 48.6% | 50.9% | 50.7% | 55.4% | ||
| Changes by years, y/y, % | -5pp | +3pp | +2pp | +2pp | 0pp | +1.3% | |||
Novo Nordisk. EBITDA margin, %
Novo Nordisk. EBITDA margin, changes, pp
Novo Nordisk (NVO) EBITDA margin US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EBITDA margin, % | ? | 59.0% | 56.7% | 41.9% | 47.1% | 71.5% | 55.4% | |
| Changes by years, y/y, % | +5pp | +6pp | -6pp | +13pp | ||||
| Changes by quarters, q/q, % | +5pp | -2pp | -15pp | +5pp | +24pp | |||
